SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

HECKMANN, J M et al. The characteristics of juvenile myasthenia gravis among South Africans. SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.6, pp.532-536. ISSN 2078-5135.

    1. Bateman KJ, Schinkel M, Little F, Liebenberg L, Vincent A, Heckmann JM. Incidence of seropositive myasthenia gravis in Cape Town and South Africa. S Afr Med J 2007;97(10):959-962. [ Links ]

    2. Rodriguez M, Gomez MR, Howard FM, Jr., Taylor WF. Myasthenia gravis in children: long-term follow-up. Ann Neurol 1983;13(5):504-510. [ Links ]

    3. Evoli A. Acquired myasthenia gravis in childhood. Curr Opin Neurol 2010;23(5):536-540. [ Links ]

    4. Heckmann JM, Owen EP, Little F. Myasthenia gravis in South Africans: racial differences in clinical manifestations. Neuromuscul Disord 2007;17(11-12):929-934. [ Links ]

    5. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000;55(1):16-23. [ Links ]

    6. Chiang LM, Darras BT, Kang PB. Juvenile myasthenia gravis. Muscle Nerve 2009;39(4):423-431. [ Links ]

    7. Mullaney P, Vajsar J, Smith R, Buncic JR. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children. Ophthalmology 2000;107(3):504-510. [ Links ]

    8. Kim JH, Hwang JM, Hwang YS, Kim KJ, Chae J. Childhood ocular myasthenia gravis. Ophthalmology 2003;110(7):1458-1462. [ Links ]

    9. Heckmann JM, Uwimpuhwe H, Ballo R, Kaur M, Bajic VB, Prince S. A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis. Genes Immun 2010;11:1-10. [] [ Links ]

    10. Andrews PI, Massey JM, Howard JF jun., Sanders DB. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology 1994;44(7):1208-1214. [ Links ]

    11. Aban IB, Wolfe GI, Cutter GR, et al. The MGTX experience: challenges in planning and executing an international, multicenter clinical trial. J Neuroimmunol 2008;201-202:80-84. [ Links ]

    12. Heckmann JM, Rawoot A, Bateman K, Renison R, Badri M. A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis. BMC Neurol 2011;11:97. [] [ Links ]